Study #2025-0837
A phase 1, open-label study of ABSK-011 to assess safety, tolerability, and pharmacokinetics in patients with advanced solid tumors
MD Anderson Study Status
Enrolling
Treatment Agent
ABSK-011
Description
This is an open-label phase 1 study with an escalation part and an expansion part.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Advanced Liver Cancer
Study phase:
Phase I
Physician name:
Sunyoung Lee
Department:
Gastrointestinal Medical Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop UT MD Anderson
Show your support for our mission through branded merchandise.